Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kopp

Showing results (61-70 of 596) with videos related to

Pageof 60
Sort By:
Pharmaceutica Acta Helvetiae|January 1, 1975
[Weak polar cardenolide of Convalleria majalis L. Allomethylose as a sugar component of Cavellaria glycosides. 13. Convalleria glycoside]W Kubelka, B Kopp, Jentzsch
Antimicrobial Agents and Chemotherapy|January 1, 1978
Sensitive bioassay for vancomycinC A Walker, B Kopp
Clinical Kidney Journal|February 2, 2013
Viruses and collapsing glomerulopathy: a brief critical reviewPreeti Chandra, Jeffrey B Kopp
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|November 14, 2017
Monika Nothacker, Ina B Kopp
Microscopy Research and Technique|May 16, 2002
Modulation of podocyte phenotype in collapsing glomerulopathiesLaura Barisoni, Jeffrey B Kopp
The Journal of Clinical Investigation|April 3, 2019
c-Src is in the effector pathway linking uPAR and podocyte injuryJeffrey B Kopp, Jurgen Heymann
Clinical Journal of the American Society of Nephrology : CJASN|July 30, 2015
Preparing for Disasters for Patients on DialysisMichael Davis, Jeffrey B Kopp
Kidney International Reports|March 11, 2020
Launching APOLLO: The Role of <i>APOL1</i> Genetic Variants in Live- and Deceased-Donor Kidney TransplantationFederico Fuentes, Jeffrey B Kopp
Seminars in Nephrology|July 28, 2012
Retinoid and TGF-β families: crosstalk in development, neoplasia, immunity, and tissue repairQihe Xu, Jeffrey B Kopp
Planta Medica|May 11, 2001
Microbiological status of commercially available medicinal herbal drugs--a screening studyE Czech, W Kneifel, B Kopp
Pageof 60

Showing results (61-70 of 596) with videos related to

Sort By:
Pageof 60
Pharmaceutica Acta Helvetiae|January 1, 1975
[Weak polar cardenolide of Convalleria majalis L. Allomethylose as a sugar component of Cavellaria glycosides. 13. Convalleria glycoside]W Kubelka, B Kopp, Jentzsch
Antimicrobial Agents and Chemotherapy|January 1, 1978
Sensitive bioassay for vancomycinC A Walker, B Kopp
Clinical Kidney Journal|February 2, 2013
Viruses and collapsing glomerulopathy: a brief critical reviewPreeti Chandra, Jeffrey B Kopp
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|November 14, 2017
Monika Nothacker, Ina B Kopp
Microscopy Research and Technique|May 16, 2002
Modulation of podocyte phenotype in collapsing glomerulopathiesLaura Barisoni, Jeffrey B Kopp
The Journal of Clinical Investigation|April 3, 2019
c-Src is in the effector pathway linking uPAR and podocyte injuryJeffrey B Kopp, Jurgen Heymann
Clinical Journal of the American Society of Nephrology : CJASN|July 30, 2015
Preparing for Disasters for Patients on DialysisMichael Davis, Jeffrey B Kopp
Kidney International Reports|March 11, 2020
Launching APOLLO: The Role of <i>APOL1</i> Genetic Variants in Live- and Deceased-Donor Kidney TransplantationFederico Fuentes, Jeffrey B Kopp
Seminars in Nephrology|July 28, 2012
Retinoid and TGF-β families: crosstalk in development, neoplasia, immunity, and tissue repairQihe Xu, Jeffrey B Kopp
Planta Medica|May 11, 2001
Microbiological status of commercially available medicinal herbal drugs--a screening studyE Czech, W Kneifel, B Kopp
Pageof 60